Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raewyn Broady

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Plos One|December 20, 2012
Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skinRichard Yu, Raewyn Broady, Yuanshen Huang, et al.
Leukemia & Lymphoma|August 27, 2016
Comparison of a pediatric-inspired treatment protocol versus standard-intensity chemotherapy for young adults with standard-risk BCR-ABL negative acute lymphoblastic leukemiaDavid Kliman, Michael Barnett, Raewyn Broady, et al.
BMJ Open|March 20, 2021
Navigating choice in the face of uncertainty: using a theory informed qualitative approach to identifying potential patient barriers and enablers to participating in an early phase chimeric antigen receptor T (CAR-T) cell therapy trialGisell Castillo, Manoj M Lalu, Sarah Asad, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2018
Improving Revised International Prognostic Scoring System Pre-Allogeneic Stem Cell Transplantation Does Not Translate Into Better Post-Transplantation Outcomes for Patients with Myelodysplastic Syndromes: A Single-Center ExperienceMusa Alzahrani, Maryse Power, Yasser Abou Mourad, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 4, 2019
Outpatient Autologous Stem Cell Transplants for Multiple Myeloma: Analysis of Safety and Outcomes in a Tertiary Care CenterShruthi Ganeshappa Kodad, Heather Sutherland, Wasithep Limvorapitak, et al.
Haematologica|July 4, 2007
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I studyMartino Introna, Gianmaria Borleri, Elena Conti, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2018
Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted AnalysisWasithep Limvorapitak, Michael J Barnett, Donna E Hogge, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 21, 2017
Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host DiseaseGeorge L Chen, Paul A Carpenter, Raewyn Broady, et al.
Leukemia & Lymphoma|December 8, 2010
Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months)Christopher P Venner, Joseph M Connors, Heather J Sutherland, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 9, 2018
Employment, Insurance, and Financial Experiences of Patients with Chronic Graft-versus-Host Disease in North AmericaNandita Khera, Betty K Hamilton, Joseph A Pidala, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Plos One|December 20, 2012
Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skinRichard Yu, Raewyn Broady, Yuanshen Huang, et al.
Leukemia & Lymphoma|August 27, 2016
Comparison of a pediatric-inspired treatment protocol versus standard-intensity chemotherapy for young adults with standard-risk BCR-ABL negative acute lymphoblastic leukemiaDavid Kliman, Michael Barnett, Raewyn Broady, et al.
BMJ Open|March 20, 2021
Navigating choice in the face of uncertainty: using a theory informed qualitative approach to identifying potential patient barriers and enablers to participating in an early phase chimeric antigen receptor T (CAR-T) cell therapy trialGisell Castillo, Manoj M Lalu, Sarah Asad, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2018
Improving Revised International Prognostic Scoring System Pre-Allogeneic Stem Cell Transplantation Does Not Translate Into Better Post-Transplantation Outcomes for Patients with Myelodysplastic Syndromes: A Single-Center ExperienceMusa Alzahrani, Maryse Power, Yasser Abou Mourad, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 4, 2019
Outpatient Autologous Stem Cell Transplants for Multiple Myeloma: Analysis of Safety and Outcomes in a Tertiary Care CenterShruthi Ganeshappa Kodad, Heather Sutherland, Wasithep Limvorapitak, et al.
Haematologica|July 4, 2007
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I studyMartino Introna, Gianmaria Borleri, Elena Conti, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2018
Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted AnalysisWasithep Limvorapitak, Michael J Barnett, Donna E Hogge, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 21, 2017
Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host DiseaseGeorge L Chen, Paul A Carpenter, Raewyn Broady, et al.
Leukemia & Lymphoma|December 8, 2010
Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months)Christopher P Venner, Joseph M Connors, Heather J Sutherland, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 9, 2018
Employment, Insurance, and Financial Experiences of Patients with Chronic Graft-versus-Host Disease in North AmericaNandita Khera, Betty K Hamilton, Joseph A Pidala, et al.
Pageof 4